Pfizer Covid Vaccine Trial Hasn’t Reached Analysis Milestone

Pfizer Inc.’s late-stage trial of an experimental coronavirus vaccine hadn’t yet reached a key milestone that will help researchers determine how well it protects people from Covid-19.